# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027430
Filing Date
2023-08-04
Accepted
2023-08-04 09:23:26
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ovid-20230630.htm iXBRL | 10-Q | 1223304
2 | EX-31.1 | ovid2023q2exhibit311.htm | EX-31.1 | 10561
3 | EX-31.2 | ovid2023q2exhibit312.htm | EX-31.2 | 10598
4 | EX-32.1 | ovid2023q2exhibit321.htm | EX-32.1 | 5682
10 |  | ovid-20230630_g1.jpg | GRAPHIC | 112892
| Complete submission text file | 0001628280-23-027430.txt |  | 6004177

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ovid-20230630.xsd | EX-101.SCH | 46100
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ovid-20230630_cal.xml | EX-101.CAL | 61995
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ovid-20230630_def.xml | EX-101.DEF | 152068
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ovid-20230630_lab.xml | EX-101.LAB | 520975
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ovid-20230630_pre.xml | EX-101.PRE | 324732
60 | EXTRACTED XBRL INSTANCE DOCUMENT | ovid-20230630_htm.xml | XML | 681327

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 231142397
SIC: 2834 Pharmaceutical Preparations